These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31368868)

  • 1. Inhibitory Mechanism of An Anticancer Drug, Bexarotene Against Amyloid β Peptide Aggregation: Repurposing Via Neuroinformatics Approach.
    Bibi N; Rizvi SMD; Batool A; Kamal MA
    Curr Pharm Des; 2019; 25(27):2989-2995. PubMed ID: 31368868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible Molecular Interactions of Bexarotene - A Retinoid Drug and Alzheimer's Aβ Peptide: A Docking Study.
    Mirza Z; Beg MA
    Curr Alzheimer Res; 2017; 14(3):327-334. PubMed ID: 27842487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OAB-14, a bexarotene derivative, improves Alzheimer's disease-related pathologies and cognitive impairments by increasing β-amyloid clearance in APP/PS1 mice.
    Yuan C; Guo X; Zhou Q; Du F; Jiang W; Zhou X; Liu P; Chi T; Ji X; Gao J; Chen C; Lang H; Xu J; Liu D; Yang Y; Qiu S; Tang X; Chen G; Zou L
    Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):161-180. PubMed ID: 30389579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bexarotene cannot reduce amyloid beta plaques through inhibition of production of amyloid beta peptides: in silico and in vitro study.
    Pham HDQ; Thai NQ; Bednarikova Z; Linh HQ; Gazova Z; Li MS
    Phys Chem Chem Phys; 2018 Sep; 20(37):24329-24338. PubMed ID: 30211407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Alzheimer's amyloid-beta aggregation in-vitro by carbenoxolone: Insight into mechanism of action.
    Sharma S; Nehru B; Saini A
    Neurochem Int; 2017 Sep; 108():481-493. PubMed ID: 28652220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory mechanism of an antifungal drug, caspofungin against amyloid β peptide aggregation: Repurposing via neuroinformatics and an experimental approach.
    Kumari A; Shrivastava N; Mishra M; Somvanshi P; Grover A
    Mol Cell Neurosci; 2021 Apr; 112():103612. PubMed ID: 33722677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bexarotene Does Not Clear Amyloid Beta Plaques but Delays Fibril Growth: Molecular Mechanisms.
    Huy PDQ; Thai NQ; Bednarikova Z; Phuc LH; Linh HQ; Gazova Z; Li MS
    ACS Chem Neurosci; 2017 Sep; 8(9):1960-1969. PubMed ID: 28689412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer's disease.
    Habchi J; Arosio P; Perni M; Costa AR; Yagi-Utsumi M; Joshi P; Chia S; Cohen SI; Müller MB; Linse S; Nollen EA; Dobson CM; Knowles TP; Vendruscolo M
    Sci Adv; 2016 Feb; 2(2):e1501244. PubMed ID: 26933687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bexarotene Promotes Cholesterol Efflux and Restricts Apical-to-Basolateral Transport of Amyloid-β Peptides in an In Vitro Model of the Human Blood-Brain Barrier.
    Kuntz M; Candela P; Saint-Pol J; Lamartinière Y; Boucau MC; Sevin E; Fenart L; Gosselet F
    J Alzheimers Dis; 2015; 48(3):849-62. PubMed ID: 26402114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bexarotene blocks calcium-permeable ion channels formed by neurotoxic Alzheimer's β-amyloid peptides.
    Fantini J; Di Scala C; Yahi N; Troadec JD; Sadelli K; Chahinian H; Garmy N
    ACS Chem Neurosci; 2014 Mar; 5(3):216-24. PubMed ID: 24383913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Norepinephrine Inhibits Alzheimer's Amyloid-β Peptide Aggregation and Destabilizes Amyloid-β Protofibrils: A Molecular Dynamics Simulation Study.
    Zou Y; Qian Z; Chen Y; Qian H; Wei G; Zhang Q
    ACS Chem Neurosci; 2019 Mar; 10(3):1585-1594. PubMed ID: 30605312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bexarotene Binds to the Amyloid Precursor Protein Transmembrane Domain, Alters Its α-Helical Conformation, and Inhibits γ-Secretase Nonselectively in Liposomes.
    Kamp F; Scheidt HA; Winkler E; Basset G; Heinel H; Hutchison JM; LaPointe LM; Sanders CR; Steiner H; Huster D
    ACS Chem Neurosci; 2018 Jul; 9(7):1702-1713. PubMed ID: 29717863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of amyloid-β aggregation in Alzheimer's disease.
    Wang Q; Yu X; Li L; Zheng J
    Curr Pharm Des; 2014; 20(8):1223-43. PubMed ID: 23713775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAGE mediates Aβ accumulation in a mouse model of Alzheimer's disease via modulation of β- and γ-secretase activity.
    Fang F; Yu Q; Arancio O; Chen D; Gore SS; Yan SS; Yan SF
    Hum Mol Genet; 2018 Mar; 27(6):1002-1014. PubMed ID: 29329433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A computational study of self-assembled hexapeptide inhibitors against amyloid-β (Aβ) aggregation.
    Qiao Y; Zhang M; Liang Y; Zheng J; Liang G
    Phys Chem Chem Phys; 2016 Dec; 19(1):155-166. PubMed ID: 27929168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
    Savelieff MG; DeToma AS; Derrick JS; Lim MH
    Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual inhibitors of β-amyloid aggregation and acetylcholinesterase as multi-target anti-Alzheimer drug candidates.
    Viayna E; Sabate R; Muñoz-Torrero D
    Curr Top Med Chem; 2013; 13(15):1820-42. PubMed ID: 23931440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of LVFFARK and LVFFARK-functionalized nanoparticles for inhibiting amyloid β-protein fibrillation and cytotoxicity.
    Xiong N; Dong XY; Zheng J; Liu FF; Sun Y
    ACS Appl Mater Interfaces; 2015 Mar; 7(10):5650-62. PubMed ID: 25700145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
    Matsuzaki K
    Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.